We work hard to attract, retain, and support the most outstanding faculty.

Aging cell

Age-related changes to macrophage subpopulations and TREM2 dysregulation characterize attenuated fracture healing in old mice.

2024

Authors: Clark D, Brazina S, Miclau T, Park S, Hsieh CL, Nakamura M, Marcucio R

Seminars in arthritis and rheumatism

The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis.

2024

Authors: Liew JW, Treu T, Park Y, Ferguson JM, Rosser MA, Ho YL, Gagnon DR, Stovall R, Monach P, Heckbert SR, Gensler LS, Liao KP, Dubreuil M

Life sciences

Implications of chronic moderate protein-deficiency malnutrition on doxorubicin pharmacokinetics and cardiotoxicity in early post-weaning stage.

2024

Authors: Garg M, Gandhi K, Gera P, Jadhav SM, Mohanty B, Gurjar M, Sandupatla B, Gala R, Chaudhari P, Prasad M, Chinnaswamy G, Gota V

Annals of the rheumatic diseases

POS0137 INITIATION OF GLUCOCORTICOIDS BEFORE ENTERING RHEUMATOLOGY CARE ASSOCIATES WITH LONG-TERM GLUCOCORTICOID USE IN ELDERLY PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A JOINT ANALYSIS OF MEDICARE AND THE RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENES

2024

Authors: A. Palmowski, E. Roberts, J. Li, E. Kersey, R. Stovall, F. Buttgereit, J. Yazdany, G. Schmajuk

Annals of the rheumatic diseases

POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES.

2024

Authors: X. Baraliakos, A. Deodhar, D. Van der Heijde, F. Van den Bosch, M. Magrey, W.P. Maksymowych, T. Tomita, H. Xu, U. Massow, C. Fleurinck, T. Vaux, C. Prajapati, J. Shepherd-Smith, A. Marten, L.S. Gensler

Annals of the rheumatic diseases

POS0194 FACTORS ASSOCIATED WITH RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS RECEIVING IL-17A INHIBITOR OR TNF INHIBITOR THERAPY: A POST-HOC ANALYSIS OF THE SURPASS STUDY.

2024

Authors: D. Poddubnyy, J. Braun, P. Machado, V. Navarro-Compán, L.S. Gensler, K.G. Hermann, E. Quebe-Fehling, C.C. Pieterse, A. Readie, C. Gaillez, X. Baraliakos

Annals of the rheumatic diseases

AB0881 LONG-TERM SAFETY AND TOLERABILITY OF BIMEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM POOLED PHASE 2B/3 STUDIES.

2024

Authors: P.J. Mease, D. Poddubnyy, A.M. Orbai, R.B. Warren, C. Fleurinck, R. Bajracharya, B. Ink, U. Massow, V. Shende, J. Shepherd-Smith, L. Peterson, K. White, R. Landewé, L.S. Gensler

Annals of the rheumatic diseases

POS0391 THE MSQUASH AS MEASUREMENT TOOL FOR DAILY PHYSICAL ACTIVITY: TRANSLATION AND CROSS-CULTURAL ADAPTATION INTO ENGLISH, FIELD-TESTING IN DIFFERENT RHEUMATIC DISEASES AND CLINICAL VALIDATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS.

2024

Authors: Y.M. Van der Kraan, L.S. Gensler, D. Paap, E. Thovmasyan, N.S. Ausma, H. Kokol, M. Carbo, K. De Leeuw, K. Van der Geest, H. Bootsma, J.P.L. Spoorenberg, S. Arends

Annals of the rheumatic diseases

POS0215 LONG-TERM SAFETY AND EFFICACY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 5-YEAR RESULTS FROM A PHASE 2B STUDY AND ITS OPEN-LABEL EXTENSION.

2024

Authors: A. Deodhar, V. Navarro-Compán, D. Poddubnyy, L.S. Gensler, S. Ramiro, T. Tomita, H. Marzo-Ortega, C. Fleurinck, T. Vaux, U. Massow, D. Van der Heijde, X. Baraliakos

Annals of the rheumatic diseases

AB0913 EFFICACY OF CERTOLIZUMAB PEGOL IN PREVENTING ANTERIOR UVEITIS FLARES COMPARED WITH STANDARD NON-BIOLOGIC TREATMENT: A MATCHED CONTROL STUDY IN HIGH-RISK PATIENTS WITH AXIAL SPONDYLOARTHRITIS.

2024

Authors: N. Haroon, Z. Baskurt, T. Chim, R. Inman, D. Paez, T. Kumke, R. Tham, M. Kim, I. Van der Horst-Bruinsma, L.S. Gensler